Form 4: Charles River Labs Exec Trades Shares

Victoria L. Creamer, EVP & Chief People Officer at Charles River Laboratories, reported transactions involving common stock, including the acquisition of 5,135 shares.

Summary

• Victoria L. Creamer, Executive Vice President and Chief People Officer of Charles River Laboratories International, Inc., reported several transactions related to the company's common stock.
• On May 29, 2026, Ms. Creamer acquired 5,135 shares of common stock at a price of $180.71 per share.
• Subsequent to this acquisition, on May 30, 2026, she disposed of 616 shares at the same price.
• On May 31, 2026, a further 194 shares were disposed of at $180.71 per share.
• Following these transactions, Ms. Creamer beneficially owns 30,051 shares of common stock directly.
• The filing also notes that unvested restricted stock units will vest annually on May 29, 2027, May 29, 2028, May 29, 2029, and May 29, 2030.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily details routine insider stock transactions and vesting schedules without significant positive or negative financial disclosures.

Positives

• Acquisition of 5,135 shares by a key executive indicates potential confidence in the company's future.
• The executive continues to hold a significant number of shares (30,051) directly, suggesting ongoing investment.
• The vesting schedule for restricted stock units indicates a long-term incentive structure for management.

Negatives

• Disposal of 810 shares (616 + 194) shortly after acquisition may suggest a need for liquidity or a less optimistic short-term outlook by the executive.

Future Outlook

The filing indicates that unvested restricted stock units will vest annually through May 29, 2030, suggesting a continued commitment and incentive structure for the reporting person.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions in the life sciences and contract research organization (CRO) sector, providing transparency into executive stock dealings.

Stakeholder Impact

• Shareholders: The transactions provide insight into executive stock activity, which can influence market perception.
• Employees: The vesting schedule for restricted stock units highlights management's long-term incentives.

Next Steps

• Vesting of restricted stock units on May 29, 2027, May 29, 2028, May 29, 2029, and May 29, 2030.

Key Dates

Keywords

Charles River Laboratories, Form 4, Insider Trading, Stock Transaction, Victoria L. Creamer, Common Stock, Beneficial Ownership, Restricted Stock Units